Skip to main content
Log in

Antirheumatic activity of methotrexate in phospholipid nanoparticles (Phosphogliv)

  • Experimental Studies
  • Published:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

The efficiency of methotrexate use in the basic therapy of rheumatoid arthritis is limited because of risk of side effects and fast drug efflux from zone of joints as well. We have developed a new stabilized form of methotrexate using phospholipid micelles of the injection form of the Phosphogliv preparation as a carrier. Phosphogliv has recently been developed in the Institute of Biomedical Chemistry (Moscow), as the emulsion of 50 nm phospholipid nanoparticles stabilized by glycyrrhizic acid. The conditions of maximal methotrexate incorporation into the phospholipid nanoparticles were optimized under control of HPLC (60% of total methotrexate was associated with nanoparticles). Methotrexate in phospholipid nanoparticles exhibited higher therapeutic efficiency in experimental adjuvant arthritis in rats than with free methotrexate. (This was evaluated by the decrease of edema and swelling of joints and inhibition of secondary inflammatory reaction.) The increase of antirheumatic activity of the developed preparation may also be attributed to the influence of glycyrrhizic acid, possessing both anti-inflammatory and immune properties. It is suggested to use a new form of methotrexate for intra-articular administration for rheumatoid arthritis treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Couvreur, P and Vauthier, C., Pharm. Res., 2006, vol. 23, pp. 1417–1450.

    Article  CAS  Google Scholar 

  2. Yih, T.C. and Al-Fandi, M., J. Cell Biochem., 2006, vol. 97, pp. 1184–1190.

    Article  CAS  Google Scholar 

  3. Drummond, D., Meyer, O., Hong, K., Kirpotin, D., and Papahadjopoulos, D., Pharmacol. Rev., 1999, vol. 51, pp. 691–743.

    CAS  Google Scholar 

  4. Dolhain, R.I., Talk, P.P., Dijkmans, B.A., De Kuiper, P., Breedveld, F.C., Miltenburg, A.M., Br. J. Rheumatol., 1998, vol. 37, pp. 502–508.

    Article  CAS  Google Scholar 

  5. Kukowska-Latallo, J.F., Candido, K.A., Cao, Z., Nigavekar, S.S., Majoros, I.J., Thomas, T.P., Balogh, L.P., Khan, M.K., and Baker, J.R., Cancer Res., 2005, vol. 65, pp. 5317–5324.

    Article  CAS  Google Scholar 

  6. Vodovozova, E.L., Evdokimov, D.V., and Molotkovskii, Yu.G., Bioorgan. Khim., 2004, vol. 30, pp. 663–665.

    CAS  Google Scholar 

  7. Ioffe, V., Kalendarev, T., Rubinstein, I., Zabetski, R., and Zupkovitz, G., J. Chromatogr A, 2004, vol. 1031, pp. 249–258.

    Article  CAS  Google Scholar 

  8. Gao, K. and Jiang, X., Int. J. Pharm., 2006, vol. 310, pp. 213–219.

    Article  CAS  Google Scholar 

  9. Kohler, N., Sun, C., Wang, J., and Zhang, M., Langmuir, 2005, vol. 21, pp. 8858–8864.

    Article  CAS  Google Scholar 

  10. Chau, Y., Tan, F.E., and Langer, R., Bioconjug. Chem., 2004, vol. 15, pp. 931–941.

    Article  CAS  Google Scholar 

  11. Ruckmani K., Sivakumar M., and Ganeshkumar P.A., J. Nanosci. Nanotechnol., 2006, vol. 6, pp. 2991–2995.

    Article  CAS  Google Scholar 

  12. Nasonov E.L., Karateev, D.E., Chichasova, N.V., and Chemeris, N.A., Klin. Farmakol. Ther, 2005 no. 1, pp. 72-75

  13. Omata, T., Segawa, Y., Inoue, N., Tsuzuike, N., Itokazu, Y., and Tamaki, H., Res. Exp. Med. (Berl.), 1997}, vol. 197, pp. 81–90.

  14. Schuerwegh, A.J., van Offel, J.F., Bridts, C.H., Stevens, W.J., and De Clerck, L.S., J. Rheumatol., 2001, vol. 28, pp. 1793–1799.

    CAS  Google Scholar 

  15. Suzuki, Y., Nakagawa, M., Masuda, C., Ide, M., Uehara, R., Ichikawa, Y., and Mizushima, Y., J. Rheumatol., 1997, vol. 24, pp. 1890–1895.

    CAS  Google Scholar 

  16. Groff, G.D., Shenberger, K.N., Wilke, W.S., and Taylor, T.H., Semin. Arthritis Rheum., 1983, vol. 12, pp. 333–347.

    Article  CAS  Google Scholar 

  17. Davydenkova, E.F., Ternova, N.K., Rozenberg, O.A., Noskin, L.A., and Loshakova, L.V., Byul. Eksper Biol. Med., 1984, vol. 97, pp. 656–658.

    Google Scholar 

  18. Bonanomi, M.H., Velvart, M., Stimpel, M., Roos, K.M., Fehr, K., and Weder, H.G., Rheumatol. Int., 1987, vol. 7, pp. 203–212.

    Article  CAS  Google Scholar 

  19. Foong, W.C. and Green, K.L., J. Pharm. Pharmacol., 1993, vol. 45, pp. 204–209.

    Article  CAS  Google Scholar 

  20. Kim, M.M., Lee, S.H., Lee, M.G., Hwang, S.J., and Kim, C.K., Biopharm. Drug Dispos., 1995, vol. 16, pp. 279–293.

    Article  CAS  Google Scholar 

  21. Williams, A.S., Camilleri, J.P., Goodfellow, R.M., and Williams, B.D., Br. J. Rheumatol., 1996, vol. 35, pp. 719–724.

    Article  CAS  Google Scholar 

  22. Archakov, A.I., Sel’tsovskii, A.P., Lisov, V.I., Tsyganov, D.I., Knyazhev, VA., Ipatova, O.M., and Torkhovskaya, T.I., Vopr Med. Khim., 2002, vol. 48, pp. 139–151.

    CAS  Google Scholar 

  23. Ipatova, O.M., Fosfogliv: mekhanism deistviya i primenenie v klinike (Phosphogliv: Mechanism of Action and Clinical Application), Academician of RAMS A.I. Archakov, Ed., Moscow: Institute of Biomedical Chemistry, RAMS, 2005.

  24. A Medicinal Preparation and Mode of Treatment of Rheumatoid Diseases, Patent Application no. 2006114078, Priority Date April 26, 2006.

  25. Fuchs, B., Schiller, J., Wagner, U., Hantzschel, H., and Arnold, K., Clin. Biochem., 2005, vol. 38, pp. 925–933.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. G. Zykova.

Additional information

Original Russian Text © M.G. Zykova, V.N. Prozorovskii, O.M. Ipatova, T.I. Torkhovskaya, V.V. Glazatov, 2008, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zykova, M.G., Prozorovskii, V.N., Ipatova, O.M. et al. Antirheumatic activity of methotrexate in phospholipid nanoparticles (Phosphogliv). Biochem. Moscow Suppl. Ser. B 2, 71–74 (2008). https://doi.org/10.1007/s11828-008-1007-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11828-008-1007-y

Key words

Navigation